Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report.
Wiener
J J
JJ
Department of Obstetrics and Gynaecology, University Hospital of Wales, Heath Park, Cardiff.
Evans
A S
AS
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects; D000032:Abortion, Therapeutic / Q000009:adverse effects*; D000328:Adult; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D010121:Oxytocin / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000139:chemically induced*
D000020:Abortifacient Agents, Nonsteroidal; C021182:gemeprost; D010121:Oxytocin; D000527:Alprostadil